Yuan Zhi
Stock Analyst at B. Riley Securities
(0.95)
# 3,763
Out of 4,896 analysts
25
Total ratings
33.33%
Success rate
-15.54%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Maintains: Buy | $9 → $12 | $3.98 | +201.51% | 3 | Jun 23, 2025 | |
| RDNT RadNet | Initiates: Buy | $69 | $55.48 | +24.37% | 1 | Jun 13, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $0.77 | +30.04% | 2 | May 15, 2025 | |
| MIR Mirion Technologies | Maintains: Buy | $19 → $17 | $20.42 | -16.75% | 2 | Apr 16, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $4.22 | +255.45% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $5.93 | +34.91% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $7.06 | +154.96% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $7.56 | +98.54% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $1.07 | +180.37% | 1 | May 15, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $33.48 | +135.96% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.52 | +952.63% | 4 | Dec 11, 2023 |
Perspective Therapeutics
Jun 23, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $3.98
Upside: +201.51%
RadNet
Jun 13, 2025
Initiates: Buy
Price Target: $69
Current: $55.48
Upside: +24.37%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $0.77
Upside: +30.04%
Mirion Technologies
Apr 16, 2025
Maintains: Buy
Price Target: $19 → $17
Current: $20.42
Upside: -16.75%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $4.22
Upside: +255.45%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $5.93
Upside: +34.91%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $7.06
Upside: +154.96%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $7.56
Upside: +98.54%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $33.48
Upside: +135.96%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.52
Upside: +952.63%